nodes	percent_of_prediction	percent_of_DWPC	metapath
Everolimus—CYP3A4—chronic kidney failure	0.709	1	CbGaD
Everolimus—MTOR—blood plasma—chronic kidney failure	0.00703	0.112	CbGeAlD
Everolimus—FKBP1A—blood plasma—chronic kidney failure	0.00632	0.101	CbGeAlD
Everolimus—CYP3A4—urine—chronic kidney failure	0.00396	0.0632	CbGeAlD
Everolimus—MTOR—renal system—chronic kidney failure	0.0033	0.0526	CbGeAlD
Everolimus—MTOR—cardiovascular system—chronic kidney failure	0.00326	0.052	CbGeAlD
Everolimus—MTOR—kidney—chronic kidney failure	0.00319	0.0508	CbGeAlD
Everolimus—FKBP1A—renal system—chronic kidney failure	0.00296	0.0473	CbGeAlD
Everolimus—MTOR—gonad—chronic kidney failure	0.00295	0.0472	CbGeAlD
Everolimus—FKBP1A—cardiovascular system—chronic kidney failure	0.00293	0.0467	CbGeAlD
Everolimus—FKBP1A—urethra—chronic kidney failure	0.00291	0.0465	CbGeAlD
Everolimus—FKBP1A—kidney—chronic kidney failure	0.00287	0.0457	CbGeAlD
Everolimus—FKBP1A—cortex of kidney—chronic kidney failure	0.00279	0.0445	CbGeAlD
Everolimus—MTOR—digestive system—chronic kidney failure	0.0027	0.0431	CbGeAlD
Everolimus—FKBP1A—gonad—chronic kidney failure	0.00266	0.0424	CbGeAlD
Everolimus—MTOR—blood—chronic kidney failure	0.00257	0.0411	CbGeAlD
Everolimus—FKBP1A—digestive system—chronic kidney failure	0.00243	0.0388	CbGeAlD
Everolimus—FKBP1A—blood—chronic kidney failure	0.00232	0.037	CbGeAlD
Everolimus—CYP3A4—blood plasma—chronic kidney failure	0.00207	0.033	CbGeAlD
Everolimus—Pimecrolimus—CYP3A4—chronic kidney failure	0.00166	0.203	CrCbGaD
Everolimus—Temsirolimus—CYP3A4—chronic kidney failure	0.00112	0.137	CrCbGaD
Everolimus—Tacrolimus—CYP3A4—chronic kidney failure	0.000985	0.12	CrCbGaD
Everolimus—Sirolimus—CYP3A4—chronic kidney failure	0.000985	0.12	CrCbGaD
Everolimus—CYP3A4—renal system—chronic kidney failure	0.000968	0.0155	CbGeAlD
Everolimus—CYP3A4—kidney—chronic kidney failure	0.000936	0.0149	CbGeAlD
Everolimus—Temsirolimus—ABCB1—chronic kidney failure	0.000932	0.114	CrCbGaD
Everolimus—Tacrolimus—ALB—chronic kidney failure	0.000859	0.105	CrCbGaD
Everolimus—Tacrolimus—ABCB1—chronic kidney failure	0.00082	0.1	CrCbGaD
Everolimus—Sirolimus—ABCB1—chronic kidney failure	0.00082	0.1	CrCbGaD
Everolimus—CYP3A4—digestive system—chronic kidney failure	0.000794	0.0127	CbGeAlD
Everolimus—CYP3A4—blood—chronic kidney failure	0.000757	0.0121	CbGeAlD
Everolimus—MTOR—ErbB1 downstream signaling—KRAS—chronic kidney failure	0.000156	0.000708	CbGpPWpGaD
Everolimus—MTOR—VEGFA-VEGFR2 Pathway—KRAS—chronic kidney failure	0.000154	0.000697	CbGpPWpGaD
Everolimus—MTOR—Disease—TFDP2—chronic kidney failure	0.000152	0.000689	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—NFKB1—chronic kidney failure	0.000151	0.000686	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—NCF1—chronic kidney failure	0.000151	0.000684	CbGpPWpGaD
Everolimus—MTOR—IRS-mediated signalling—IL6—chronic kidney failure	0.00015	0.000682	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—COL4A3—chronic kidney failure	0.00015	0.000682	CbGpPWpGaD
Everolimus—FKBP1A—Disease—NCF1—chronic kidney failure	0.00015	0.000681	CbGpPWpGaD
Everolimus—MTOR—Disease—PIP5K1B—chronic kidney failure	0.000149	0.000674	CbGpPWpGaD
Everolimus—MTOR—IRS-related events—IL6—chronic kidney failure	0.000146	0.000663	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—RELA—chronic kidney failure	0.000146	0.000663	CbGpPWpGaD
Everolimus—MTOR—Signaling by VEGF—KRAS—chronic kidney failure	0.000145	0.000658	CbGpPWpGaD
Everolimus—MTOR—IRS-related events triggered by IGF1R—IL6—chronic kidney failure	0.000145	0.000657	CbGpPWpGaD
Everolimus—MTOR—Signaling by Insulin receptor—KRAS—chronic kidney failure	0.000144	0.000653	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—CYP2C18—chronic kidney failure	0.000143	0.00065	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CRHR1—chronic kidney failure	0.000143	0.00065	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CYBA—chronic kidney failure	0.000142	0.000643	CbGpPWpGaD
Everolimus—CYP3A4—Metapathway biotransformation—CYP2C18—chronic kidney failure	0.000141	0.000641	CbGpPWpGaD
Everolimus—FKBP1A—Disease—CYBA—chronic kidney failure	0.000141	0.000641	CbGpPWpGaD
Everolimus—MTOR—IGF1R signaling cascade—IL6—chronic kidney failure	0.000141	0.00064	CbGpPWpGaD
Everolimus—MTOR—Insulin receptor signalling cascade—IL6—chronic kidney failure	0.000141	0.00064	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—chronic kidney failure	0.00014	0.000633	CbGpPWpGaD
Everolimus—FKBP1A—Disease—FASN—chronic kidney failure	0.000139	0.00063	CbGpPWpGaD
Everolimus—MTOR—Immune System—KEAP1—chronic kidney failure	0.000138	0.000625	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—LRP2—chronic kidney failure	0.000138	0.000623	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—VEGFA—chronic kidney failure	0.000137	0.000622	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—IRS1—chronic kidney failure	0.000136	0.000617	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—NFKB1—chronic kidney failure	0.000133	0.000604	CbGpPWpGaD
Everolimus—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic kidney failure	0.000132	0.000598	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PTH—chronic kidney failure	0.000131	0.000595	CbGpPWpGaD
Everolimus—FKBP1A—Disease—NOS1—chronic kidney failure	0.00013	0.00059	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—HBEGF—chronic kidney failure	0.00013	0.000588	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CYBB—chronic kidney failure	0.000128	0.000579	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—IL6—chronic kidney failure	0.000127	0.000576	CbGpPWpGaD
Everolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—chronic kidney failure	0.000125	0.000567	CbGpPWpGaD
Everolimus—MTOR—Immune System—MYH9—chronic kidney failure	0.000125	0.000566	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CD79A—chronic kidney failure	0.000125	0.000565	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—HBEGF—chronic kidney failure	0.000125	0.000565	CbGpPWpGaD
Everolimus—FKBP1A—Disease—HBEGF—chronic kidney failure	0.000124	0.000563	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—KRAS—chronic kidney failure	0.000123	0.000559	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—NFKB1—chronic kidney failure	0.000123	0.000559	CbGpPWpGaD
Everolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—chronic kidney failure	0.000121	0.00055	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—FGF23—chronic kidney failure	0.000121	0.000549	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—CYP2C19—chronic kidney failure	0.000119	0.000539	CbGpPWpGaD
Everolimus—MTOR—Signaling by VEGF—IL6—chronic kidney failure	0.000118	0.000535	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—KRAS—chronic kidney failure	0.000118	0.000535	CbGpPWpGaD
Everolimus—MTOR—Signaling by Insulin receptor—IL6—chronic kidney failure	0.000117	0.000532	CbGpPWpGaD
Everolimus—CYP3A4—Metapathway biotransformation—CYP2C19—chronic kidney failure	0.000117	0.000531	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—KRAS—chronic kidney failure	0.000117	0.000529	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—KRAS—chronic kidney failure	0.000116	0.000526	CbGpPWpGaD
Everolimus—MTOR—Disease—GCKR—chronic kidney failure	0.000115	0.000522	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—RELA—chronic kidney failure	0.000115	0.00052	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—COL4A5—chronic kidney failure	0.000114	0.000519	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NPY—chronic kidney failure	0.000114	0.000516	CbGpPWpGaD
Everolimus—MTOR—Immune System—CYBB—chronic kidney failure	0.000111	0.000504	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—KRAS—chronic kidney failure	0.000111	0.000503	CbGpPWpGaD
Everolimus—MTOR—Disease—LRP2—chronic kidney failure	0.00011	0.000501	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—KRAS—chronic kidney failure	0.00011	0.0005	CbGpPWpGaD
Everolimus—MTOR—EGF/EGFR Signaling Pathway—KRAS—chronic kidney failure	0.00011	0.0005	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—OXT—chronic kidney failure	0.00011	0.000498	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CRH—chronic kidney failure	0.00011	0.000498	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—KRAS—chronic kidney failure	0.00011	0.000498	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—KRAS—chronic kidney failure	0.000109	0.000495	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—PTGS1—chronic kidney failure	0.000109	0.000493	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—KRAS—chronic kidney failure	0.000108	0.000488	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—RELA—chronic kidney failure	0.000108	0.000488	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TFDP2—chronic kidney failure	0.000106	0.000482	CbGpPWpGaD
Everolimus—MTOR—Immune System—FGF23—chronic kidney failure	0.000105	0.000477	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NCF1—chronic kidney failure	0.000105	0.000477	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NPS—chronic kidney failure	0.000104	0.000472	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PIP5K1B—chronic kidney failure	0.000104	0.000472	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—KRAS—chronic kidney failure	0.000103	0.000466	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—KRAS—chronic kidney failure	0.000103	0.000466	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—KRAS—chronic kidney failure	0.000103	0.000466	CbGpPWpGaD
Everolimus—MTOR—Disease—CYBB—chronic kidney failure	0.000103	0.000465	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—DRD1—chronic kidney failure	0.000102	0.000463	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—KRAS—chronic kidney failure	0.000102	0.000462	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—KRAS—chronic kidney failure	0.000101	0.000458	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—KRAS—chronic kidney failure	0.000101	0.000456	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—IL6—chronic kidney failure	0.0001	0.000455	CbGpPWpGaD
Everolimus—FKBP1A—Disease—LPL—chronic kidney failure	9.93e-05	0.00045	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CYBA—chronic kidney failure	9.9e-05	0.000449	CbGpPWpGaD
Everolimus—CYP3A4—Phase 1 - Functionalization of compounds—POMC—chronic kidney failure	9.83e-05	0.000446	CbGpPWpGaD
Everolimus—MTOR—Disease—CST3—chronic kidney failure	9.72e-05	0.000441	CbGpPWpGaD
Everolimus—MTOR—Disease—FGF23—chronic kidney failure	9.72e-05	0.000441	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—NFKB1—chronic kidney failure	9.68e-05	0.000439	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—IL6—chronic kidney failure	9.6e-05	0.000435	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—KRAS—chronic kidney failure	9.51e-05	0.000431	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PGF—chronic kidney failure	9.49e-05	0.00043	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—IL6—chronic kidney failure	9.45e-05	0.000428	CbGpPWpGaD
Everolimus—MTOR—Immune System—NCF1—chronic kidney failure	9.16e-05	0.000415	CbGpPWpGaD
Everolimus—FKBP1A—Disease—CCR5—chronic kidney failure	9.15e-05	0.000415	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—KRAS—chronic kidney failure	9.11e-05	0.000413	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—NFKB1—chronic kidney failure	9.08e-05	0.000411	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—IL6—chronic kidney failure	9.02e-05	0.000409	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—IL6—chronic kidney failure	8.98e-05	0.000407	CbGpPWpGaD
Everolimus—FKBP1A—Disease—MTHFR—chronic kidney failure	8.94e-05	0.000405	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—IL6—chronic kidney failure	8.93e-05	0.000405	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PRKAG2—chronic kidney failure	8.92e-05	0.000404	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—CRP—chronic kidney failure	8.9e-05	0.000403	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—IL6—chronic kidney failure	8.89e-05	0.000403	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—VEGFA—chronic kidney failure	8.78e-05	0.000398	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—HBEGF—chronic kidney failure	8.69e-05	0.000394	CbGpPWpGaD
Everolimus—MTOR—Immune System—CYBA—chronic kidney failure	8.61e-05	0.00039	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—COL4A3—chronic kidney failure	8.46e-05	0.000383	CbGpPWpGaD
Everolimus—MTOR—Disease—NCF1—chronic kidney failure	8.46e-05	0.000383	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—chronic kidney failure	8.36e-05	0.000379	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—IL6—chronic kidney failure	8.36e-05	0.000379	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—IL6—chronic kidney failure	8.36e-05	0.000379	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—IL6—chronic kidney failure	8.29e-05	0.000376	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—IL6—chronic kidney failure	8.22e-05	0.000372	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—IL6—chronic kidney failure	8.18e-05	0.000371	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CRHR1—chronic kidney failure	8.07e-05	0.000366	CbGpPWpGaD
Everolimus—MTOR—Disease—CYBA—chronic kidney failure	7.95e-05	0.00036	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—ICAM1—chronic kidney failure	7.85e-05	0.000356	CbGpPWpGaD
Everolimus—MTOR—Disease—FASN—chronic kidney failure	7.81e-05	0.000354	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—IRS1—chronic kidney failure	7.77e-05	0.000352	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—LRP2—chronic kidney failure	7.73e-05	0.000351	CbGpPWpGaD
Everolimus—MTOR—Immune System—CD79A—chronic kidney failure	7.56e-05	0.000343	CbGpPWpGaD
Everolimus—MTOR—Immune System—HBEGF—chronic kidney failure	7.56e-05	0.000343	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—AVP—chronic kidney failure	7.53e-05	0.000342	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—IRS1—chronic kidney failure	7.46e-05	0.000338	CbGpPWpGaD
Everolimus—FKBP1A—Disease—IRS1—chronic kidney failure	7.43e-05	0.000337	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—chronic kidney failure	7.41e-05	0.000336	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PTH—chronic kidney failure	7.38e-05	0.000334	CbGpPWpGaD
Everolimus—MTOR—Disease—NOS1—chronic kidney failure	7.32e-05	0.000332	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CYBB—chronic kidney failure	7.19e-05	0.000326	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—EDN1—chronic kidney failure	7.17e-05	0.000325	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CCL5—chronic kidney failure	7.11e-05	0.000322	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—CYP1A1—chronic kidney failure	7.01e-05	0.000318	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—KRAS—chronic kidney failure	7e-05	0.000317	CbGpPWpGaD
Everolimus—MTOR—Disease—HBEGF—chronic kidney failure	6.98e-05	0.000316	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—LPL—chronic kidney failure	6.95e-05	0.000315	CbGpPWpGaD
Everolimus—CYP3A4—Metapathway biotransformation—CYP1A1—chronic kidney failure	6.91e-05	0.000313	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—FGF23—chronic kidney failure	6.81e-05	0.000309	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NGF—chronic kidney failure	6.59e-05	0.000299	CbGpPWpGaD
Everolimus—FKBP1A—Disease—SERPINE1—chronic kidney failure	6.53e-05	0.000296	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NPY—chronic kidney failure	6.41e-05	0.00029	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CCR5—chronic kidney failure	6.41e-05	0.00029	CbGpPWpGaD
Everolimus—FKBP1A—Disease—NOS3—chronic kidney failure	6.24e-05	0.000283	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—OXT—chronic kidney failure	6.18e-05	0.00028	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CRH—chronic kidney failure	6.18e-05	0.00028	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—RELA—chronic kidney failure	6.14e-05	0.000278	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—IL6—chronic kidney failure	6.07e-05	0.000275	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NCF1—chronic kidney failure	5.92e-05	0.000268	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—RELA—chronic kidney failure	5.89e-05	0.000267	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NPS—chronic kidney failure	5.86e-05	0.000266	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—DRD1—chronic kidney failure	5.75e-05	0.000261	CbGpPWpGaD
Everolimus—FKBP1A—Disease—PTGS2—chronic kidney failure	5.7e-05	0.000259	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—IL6—chronic kidney failure	5.7e-05	0.000258	CbGpPWpGaD
Everolimus—MTOR—Disease—LPL—chronic kidney failure	5.58e-05	0.000253	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CYBA—chronic kidney failure	5.57e-05	0.000252	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—F2—chronic kidney failure	5.5e-05	0.000249	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—POMC—chronic kidney failure	5.22e-05	0.000237	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IRS1—chronic kidney failure	5.2e-05	0.000236	CbGpPWpGaD
Everolimus—MTOR—Immune System—CRP—chronic kidney failure	5.18e-05	0.000235	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—NFKB1—chronic kidney failure	5.18e-05	0.000235	CbGpPWpGaD
Everolimus—MTOR—Disease—CCR5—chronic kidney failure	5.15e-05	0.000233	CbGpPWpGaD
Everolimus—MTOR—Disease—MTHFR—chronic kidney failure	5.03e-05	0.000228	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—POMC—chronic kidney failure	5.01e-05	0.000227	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—NFKB1—chronic kidney failure	4.97e-05	0.000225	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—FABP1—chronic kidney failure	4.93e-05	0.000223	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CCL2—chronic kidney failure	4.9e-05	0.000222	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HBEGF—chronic kidney failure	4.89e-05	0.000222	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IGF1—chronic kidney failure	4.82e-05	0.000218	CbGpPWpGaD
Everolimus—MTOR—Immune System—ICAM1—chronic kidney failure	4.76e-05	0.000216	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—AGXT—chronic kidney failure	4.67e-05	0.000212	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GATM—chronic kidney failure	4.67e-05	0.000212	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—SERPINE1—chronic kidney failure	4.57e-05	0.000207	CbGpPWpGaD
Everolimus—MTOR—Immune System—IRS1—chronic kidney failure	4.52e-05	0.000205	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NOS3—chronic kidney failure	4.37e-05	0.000198	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ACAT1—chronic kidney failure	4.27e-05	0.000194	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—AVP—chronic kidney failure	4.24e-05	0.000192	CbGpPWpGaD
Everolimus—MTOR—Disease—IRS1—chronic kidney failure	4.18e-05	0.000189	CbGpPWpGaD
Everolimus—FKBP1A—Disease—TGFB1—chronic kidney failure	4.12e-05	0.000187	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—RELA—chronic kidney failure	4.11e-05	0.000186	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—EDN1—chronic kidney failure	4.03e-05	0.000183	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCL5—chronic kidney failure	4e-05	0.000181	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—KRAS—chronic kidney failure	3.99e-05	0.000181	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—MLXIPL—chronic kidney failure	3.97e-05	0.00018	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—LPL—chronic kidney failure	3.91e-05	0.000177	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—KRAS—chronic kidney failure	3.84e-05	0.000174	CbGpPWpGaD
Everolimus—FKBP1A—Disease—KRAS—chronic kidney failure	3.82e-05	0.000173	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NGF—chronic kidney failure	3.7e-05	0.000168	CbGpPWpGaD
Everolimus—MTOR—Disease—SERPINE1—chronic kidney failure	3.67e-05	0.000167	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—SLC22A2—chronic kidney failure	3.63e-05	0.000165	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCR5—chronic kidney failure	3.6e-05	0.000163	CbGpPWpGaD
Everolimus—MTOR—Immune System—RELA—chronic kidney failure	3.58e-05	0.000162	CbGpPWpGaD
Everolimus—MTOR—Disease—NOS3—chronic kidney failure	3.51e-05	0.000159	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NFKB1—chronic kidney failure	3.47e-05	0.000157	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ABCG1—chronic kidney failure	3.38e-05	0.000153	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PIP5K1B—chronic kidney failure	3.3e-05	0.00015	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—IL6—chronic kidney failure	3.25e-05	0.000147	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ARG2—chronic kidney failure	3.24e-05	0.000147	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL1B—chronic kidney failure	3.23e-05	0.000147	CbGpPWpGaD
Everolimus—MTOR—Disease—PTGS2—chronic kidney failure	3.21e-05	0.000145	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—LCAT—chronic kidney failure	3.17e-05	0.000144	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—VEGFA—chronic kidney failure	3.15e-05	0.000143	CbGpPWpGaD
Everolimus—FKBP1A—Disease—IL6—chronic kidney failure	3.11e-05	0.000141	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—F2—chronic kidney failure	3.09e-05	0.00014	CbGpPWpGaD
Everolimus—MTOR—Immune System—NFKB1—chronic kidney failure	3.02e-05	0.000137	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IRS1—chronic kidney failure	2.92e-05	0.000133	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—DDC—chronic kidney failure	2.91e-05	0.000132	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TGFB1—chronic kidney failure	2.89e-05	0.000131	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PRKAG2—chronic kidney failure	2.83e-05	0.000128	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CYP2B6—chronic kidney failure	2.83e-05	0.000128	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PRKD1—chronic kidney failure	2.83e-05	0.000128	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—POMC—chronic kidney failure	2.82e-05	0.000128	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCL2—chronic kidney failure	2.76e-05	0.000125	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IGF1—chronic kidney failure	2.71e-05	0.000123	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—KRAS—chronic kidney failure	2.67e-05	0.000121	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—SREBF2—chronic kidney failure	2.65e-05	0.00012	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—SERPINE1—chronic kidney failure	2.57e-05	0.000117	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GCKR—chronic kidney failure	2.56e-05	0.000116	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ABCC3—chronic kidney failure	2.56e-05	0.000116	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—LPIN1—chronic kidney failure	2.5e-05	0.000114	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NOS3—chronic kidney failure	2.46e-05	0.000111	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—LRP2—chronic kidney failure	2.45e-05	0.000111	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CYP2C18—chronic kidney failure	2.45e-05	0.000111	CbGpPWpGaD
Everolimus—MTOR—Immune System—KRAS—chronic kidney failure	2.33e-05	0.000105	CbGpPWpGaD
Everolimus—MTOR—Disease—TGFB1—chronic kidney failure	2.32e-05	0.000105	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—RELA—chronic kidney failure	2.31e-05	0.000105	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IL6—chronic kidney failure	2.18e-05	9.86e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—KRAS—chronic kidney failure	2.15e-05	9.74e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CPT1A—chronic kidney failure	2.09e-05	9.46e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—LIPC—chronic kidney failure	2.03e-05	9.21e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CYP2C19—chronic kidney failure	2.03e-05	9.21e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NFKB1—chronic kidney failure	1.95e-05	8.84e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL6—chronic kidney failure	1.89e-05	8.58e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—SCARB1—chronic kidney failure	1.88e-05	8.51e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PTGS1—chronic kidney failure	1.86e-05	8.43e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—SREBF1—chronic kidney failure	1.82e-05	8.26e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—HMGCR—chronic kidney failure	1.77e-05	8.04e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—VEGFA—chronic kidney failure	1.77e-05	8.02e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—IL6—chronic kidney failure	1.75e-05	7.92e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—FASN—chronic kidney failure	1.74e-05	7.87e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TGFB1—chronic kidney failure	1.62e-05	7.36e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ABCA1—chronic kidney failure	1.58e-05	7.17e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—KRAS—chronic kidney failure	1.5e-05	6.82e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CAT—chronic kidney failure	1.34e-05	6.07e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ABCB1—chronic kidney failure	1.3e-05	5.9e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—LPL—chronic kidney failure	1.24e-05	5.62e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IL6—chronic kidney failure	1.22e-05	5.55e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CYP1A1—chronic kidney failure	1.2e-05	5.43e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—MTHFR—chronic kidney failure	1.12e-05	5.06e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PPARA—chronic kidney failure	1.1e-05	4.97e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—POMC—chronic kidney failure	8.93e-06	4.05e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ALB—chronic kidney failure	8.14e-06	3.69e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—NOS3—chronic kidney failure	7.79e-06	3.53e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PTGS2—chronic kidney failure	7.12e-06	3.23e-05	CbGpPWpGaD
